Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_assertion type Assertion NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_head.
- NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_assertion description "[In conclusion, radioiodide treatment after NIS gene transfer appears to be a promising novel approach in the therapy of neuroendocrine tumors if its highly encouraging in vitro effectiveness can be transferred to the in vivo situation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_provenance.
- NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_assertion evidence source_evidence_literature NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_provenance.
- NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_assertion SIO_000772 12649195 NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_provenance.
- NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_assertion wasDerivedFrom befree-20140225 NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_provenance.
- NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_assertion wasGeneratedBy ECO_0000203 NP650794.RACL1m9TePJyWPCZrNPebnxeaDR_bU7bAwtiA9t0RQ77k130_provenance.